Education
About Us
Working with TipRanks
Follow Us
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
Total Valuation
AstraZeneca Pharma India Limited has a market cap or net worth of ₹222.07B. The enterprise value is ₹48.54B.
Market Cap₹222.07B
Enterprise Value₹48.54B
Share Statistics
AstraZeneca Pharma India Limited has 25,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AstraZeneca Pharma India Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 19.28%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)19.28%
Return on Capital Employed (ROCE)0.26
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.13
Inventory Turnover1.76
Valuation Ratios
The current PE Ratio of AstraZeneca Pharma India Limited is 183.43. AstraZeneca Pharma India Limited’s PEG ratio is 1.29.
PE Ratio183.43
PS Ratio0.00
PB Ratio18.26
Price to Fair Value27.56
Price to FCF759.88
Price to Operating Cash Flow466.51
PEG Ratio1.29
Income Statement
In the last 12 months, AstraZeneca Pharma India Limited had revenue of 17.16B and earned 1.16B in profits. Earnings per share was 46.30.
Revenue17.16B
Gross Profit7.53B
Operating Income2.14B
Pretax Income1.56B
Net Income1.16B
EBITDA1.98B
Earnings Per Share (EPS)46.30
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
AstraZeneca Pharma India Limited pays an annual dividend of ₹24, resulting in a dividend yield of 0.27%
Dividend Per Share₹24
Dividend Yield0.27%
Payout Ratio51.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change39.70%
50-Day Moving Average8.78K
200-Day Moving Average7.60K
Relative Strength Index (RSI)42.86
Average Volume (3m)5.80K
Important Dates
AstraZeneca Pharma India Limited upcoming earnings date is Aug 11, 2025, TBA (Confirmed).
Last Earnings DateMay 30, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateJul 05, 2024
Financial Position
AstraZeneca Pharma India Limited as a current ratio of 1.91, with Debt / Equity ratio of 0.64%
Current Ratio1.91
Quick Ratio1.13
Debt to Market Cap0.00
Net Debt to EBITDA-2.53
Interest Coverage Ratio146.56
Taxes
In the past 12 months, AstraZeneca Pharma India Limited has paid 406.20M in taxes.
Income Tax406.20M
Effective Tax Rate0.26
Enterprise Valuation
AstraZeneca Pharma India Limited EV to EBITDA ratio is 104.80, with an EV/FCF ratio of 325.88.
EV to Sales12.08
EV to EBITDA104.80
EV to Free Cash Flow325.88
EV to Operating Cash Flow317.16
Balance Sheet
AstraZeneca Pharma India Limited has ₹4.97B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹4.97B billion.
Cash & Marketable Securities₹4.97B
Total Debt₹0.00
Net Cash-₹4.97B
Net Cash Per Share-₹198.71
Tangible Book Value Per Share₹308.16
Margins
Gross margin is 48.03%, with operating margin of 12.47%, and net profit margin of 6.74%.
Gross Margin48.03%
Operating Margin12.47%
Pretax Margin9.11%
Net Profit Margin6.74%
EBITDA Margin11.53%
EBIT Margin9.20%
Analyst Forecast
The average price target for AstraZeneca Pharma India Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―